KURA ONCOLOGY INC's ticker is KURA and the CUSIP is 50127T109. A total of 105 filers reported holding KURA ONCOLOGY INC in Q1 2019. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2021 | $4,276,000 | -7.7% | 228,318 | +2.7% | 1.36% | +18.3% |
| Q2 2021 | $4,634,000 | -23.2% | 222,263 | +4.1% | 1.15% | -6.0% |
| Q1 2021 | $6,035,000 | +39.7% | 213,471 | +61.4% | 1.22% | +38.6% |
| Q4 2020 | $4,320,000 | +350.5% | 132,283 | +322.9% | 0.88% | +365.3% |
| Q3 2020 | $959,000 | +37.8% | 31,283 | -26.7% | 0.19% | -6.4% |
| Q2 2020 | $696,000 | -65.7% | 42,683 | -70.4% | 0.20% | -72.5% |
| Q4 2018 | $2,028,000 | -84.1% | 144,411 | -80.1% | 0.74% | -83.1% |
| Q3 2018 | $12,727,000 | -16.5% | 727,258 | -13.2% | 4.37% | -48.2% |
| Q2 2018 | $15,244,000 | +23.7% | 837,604 | +27.4% | 8.43% | +13.8% |
| Q1 2018 | $12,326,000 | +105.5% | 657,411 | +67.7% | 7.41% | +118.9% |
| Q4 2017 | $5,998,000 | +45.5% | 392,027 | +42.2% | 3.38% | +58.2% |
| Q3 2017 | $4,122,000 | – | 275,731 | – | 2.14% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| ARCH Venture Management, LLC | 206,307 | $3,363,000 | 11.31% |
| Foresite Capital Management IV, LLC | 1,307,982 | $21,320,000 | 10.39% |
| EcoR1 Capital, LLC | 4,608,529 | $75,119,000 | 5.55% |
| Prosight Management, LP | 685,000 | $11,166,000 | 4.79% |
| ACUTA CAPITAL PARTNERS, LLC | 872,500 | $14,222,000 | 4.11% |
| BVF INC/IL | 2,775,882 | $45,247,000 | 2.79% |
| VR Adviser, LLC | 575,000 | $9,373,000 | 2.24% |
| ALETHEA CAPITAL MANAGEMENT, LLC | 216,171 | $3,524,000 | 2.06% |
| DAFNA Capital Management LLC | 294,260 | $4,796,000 | 1.38% |
| Vivo Capital, LLC | 1,050,000 | $17,115,000 | 1.23% |